Tofacitinib in the Treatment of Ulcerative Colitis

Speciality: Gastroenterology


Speaker:

Dr. Ajit Sood | Prof. & Head, Department of Gastroenterology

Dr Bincy P. Abraham | MD, MS, AGAF, FACG, Professor of Clinical Medicine

Dr. Rupa Banerjee | Sr. Consultant Gastroenterologist, Director

Description:

A warm welcome to all the medical professionals in this interesting session of Tofacitinib in the treatment of Ulcerative Colitis.. We have Prof. Anand N. Malaviya, Dr Indrajit Agrawal, and Dr Sanjiv Kapoor to lead the session.

Ulcerative colitis treatment usually involves either medication therapy or surgery. Different categories of medications can help in treating ulcerative colitis.

Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases, which eventually helps in controlling different inflammatory diseases. 

Oral formulation of tofacitinib has been approved for the treatment of patients with moderate–severe ulcerative colitis as Tofacitinib and other JAK inhibitors address an unmet need in the armamentarium of IBD therapy. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

2.

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

3.

What Role Should Genomic Classifier Testing Play in Prostate Cancer?

4.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

5.

Squeezing through tiny blood vessels may trigger melanoma cells to spread


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot